Wave Life Sciences Ltd. Forecast, price target & analysts
Wave Life Sciences Ltd. Target price 2026 - Analyst rating & recommendation
Wave Life Sciences Ltd. Classifications & Recommendation
Wave Life Sciences Ltd. Price Target
| Target Price | $15.30 |
| Price | $3.28 |
| Potential |
366.46%
register free of charge
|
| Number of Estimates | 18 |
|
18 Analysts have issued a price target Wave Life Sciences Ltd. 2027 .
The average Wave Life Sciences Ltd. target price is $15.30.
This is
366.46%
register free of charge
$44.10
1,244.51%
register free of charge
$12.12
269.51%
register free of charge
|
|
| A rating was issued by 21 analysts: 20 Analysts recommend Wave Life Sciences Ltd. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Wave Life Sciences Ltd. stock has an average upside potential 2027 of
366.46%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 42.73 | 50.81 |
| 60.54% | 18.92% | |
| EBITDA Margin | -496.00% | -460.31% |
| 404.33% | 7.20% | |
| Net Margin | -478.31% | -439.16% |
| 433.97% | 8.18% |
18 Analysts have issued a sales forecast Wave Life Sciences Ltd. 2026 . The average Wave Life Sciences Ltd. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Wave Life Sciences Ltd. EBITDA forecast 2026. The average Wave Life Sciences Ltd. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
18 Wave Life Sciences Ltd. Analysts have issued a net profit forecast 2026. The average Wave Life Sciences Ltd. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.21 | -1.15 |
| 72.86% | 4.96% | |
| P/E | negative | |
| EV/Sales | 4.62 |
18 Analysts have issued a Wave Life Sciences Ltd. forecast for earnings per share. The average Wave Life Sciences Ltd. EPS is
This results in the following potential growth metrics and future valuations:
Wave Life Sciences Ltd....
Current Wave Life Sciences Ltd. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Oct 01 2026 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Citigroup |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | May 20 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Oct 01 2026 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
May 20 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
